Despite its popularity in the food and chemical industries, continuous manufacturing in pharmaceutical tablet production has not been well adopted. However, there are diverse advantages of this method. Here, GEA assess the specific benefits
Dexter Tjoa, director of corporate strategy, Tjoapack, discusses what he has found challenging and highlights the opportunities he has experienced for the year.
Pharmaceutical companies are unwittingly putting production processes at risk of contamination by fitting mechanical seals which fail to comply with EU regulations. says John Smiddy, European Sales and Technical Support Director for AESSEAL.
Do you encounter difficulties when swallowing tablets? Head of product development at Catalent Pharma Solutions, Ralph Gosden, reveals why the Zydis platform is still a game changer, and what is on the cards for the near future.
Dr Liz Covey-Crump director of Business Development at Lhasa Limited describes the opportunities, challenges and trends she has experienced over the course of 2017.
Dr Hani El-Sabbahy, a biopharmaceutical application engineering specialist at science-based technology company 3M, outlines some of the challenges associated with continuous multicolumn protein A chromatography.
In this article, Jamie Clayton, Freeman Technology, considers the challenge of implementing continuous tablet production and evaluates dynamic powder characterisation as a technique to support the development of a continuous wet granulation process.
Mark Quick, executive vice president of corporate development, Recipharm, goes into detail about the opportunities his company has faced this year as well as the challenges.
Michael Avraam, global product manager at ChargePoint Technology for the PharmaSafe range of products, gives us a rundown of his sector highlights of 2017.
One of the potential pitfalls when preparing a product launch is planning for GMP inspections. An upside of recent events, is worksharing, leading towards a more globalised market. In this article Vikash Patel, ELC Group tells us more...
